Cited 39 times since 2011 (3.1 per year) source: EuropePMC Nature reviews. Cardiology, Volume 9, Issue 2, 11 2 2011, Pages 79-90 Restenosis after PCI. Part 2: prevention and therapy. Jukema JW, Ahmed TA, Verschuren JJ, Quax PH
The techniques and materials used during percutaneous coronary intervention have advanced considerably over the past 3 decades, yet restenosis remains one of the major drawbacks of this procedure. Many innovative technologies, including drug-eluting stents, with or without specific polymers, and fully biodegradable stents have been and continue to be developed in the search for a safe and effective antirestenosis therapy. Remarkable advances in stent design and nanoparticle delivery systems ('nanovehicles') have already fueled revolutionary changes in the prevention and treatment of in-stent restenosis. In this Review we provide an overview of the latest innovations for optimizing outcomes of coronary stenting, and up-to-date information about prevention and treatment of in-stent restenosis.
